Fluent® Pro Fluid Management System

    Introducing the next generation of fluid management, designed to increase efficiency, confidence and performance in your operating room.

    all medical device with display screen and blue components in a surgical room.

      Overview

      Documents

      Training

      Elevate Your Hysteroscopic Procedures.

      Your hysteroscopic solutions now benefit from our improved fluid management system. The Fluent Pro system was designed to optimize your MyoSure® tissue removal procedures with better suction, visualization and resection.

      Achieve up to 4x Faster Suction1

      Select between three adjustable levels of suction for resection of simple-to-complex pathology and notice faster draining from under the buttocks drape.1

      Experience SmartFlo™ Technology

      This unique technology collects inflow rate data and proactively adjusts to deliver consistent pressure during each procedure, optimizing visualization.2

      Resect up to 2.5x More Tissue3

      Maximize MyoSure tissue resection with the combination of the Fluent Pro system adjustable suction levels and the 10mmHg pressure setpoint decrease during cutting.3

      Better Together™

      The Fluent Pro fluid management system is designed to optimize your MyoSure tissue removal procedures.

      The Fluent Pro system high suction setting resects:1

      • 2.5x more tissue with MyoSure XL device.

      • 2x more tissue with MyoSure Lite device.

      • 1.7x more tissue with MyoSure Reach device.
         

      Experience the power of the MyoSure + Fluent Pro system.

      Enhanced User Experience

      The Fluent Pro system's touchscreen user interface streamlines tissue removal procedures from start to finish, making setup easier, enabling control during the procedure and providing convenient post-procedure data.

      Guided user interface

      Guided setup and integrated help screens are available at each step of the procedure.

      Intrauterine pressure displays

      Monitor both the set point and real-time intrauterine pressure simultaneously during a procedure.

      Adjustable suction control

      Choose from three levels of suction: low, medium, high.

      Procedure summary data

      Final deficit, fluid-in volume and cutting time appear on the summary screen post-procedure and can be accessed from the launch screen under last procedure.

      Need Support?

      All Other Requests

      Streamlined Workflow

      The Fluent Pro fluid management system has a thoughtfully refined console that enables easy setup and practical procedure workflow, with disposable components that simplify post-procedure processes.

      Easy Eject™ retention levers

      Easy Eject retention levers secure disposables in place while in use and allow for easy removal after use.

      Tissue trap design

      The tether and basket design simplifies workflow during removal or replacement of the tissue sock, preventing fluid backup.

      Canister-free system

      The disposable waste bag and FloPak™ cartridges eliminate the need to disinfect and replace canisters.

      Recessed waste bag compartment

      The protected waste bag is designed to avoid unintentional interactions and minimize case disruptions.

        1. Based on a comparison of bench testing performed on the Fluent Pro system high suction setting and the Fluent system default/non-adjustable setting. 2. Based on a survey of 34 physician users during Fluent Pro Limited Market Release, 2024. WEB-02128-001_01 3. Based on a comparison of bench testing performed on the Fluent Pro system high suction setting and the Fluent system default/non-adjustable setting using the MyoSure XL device.

        Documents

        Safety Data Sheets

        Package Inserts

        Panther Fusion® Respiratory Assays

        Placeholder image

          Overview

          Package Inserts

          Resources

          Syndromic Respiratory Testing.

          Patient-Specific Results.

          The Panther Fusion Respiratory assays are the premier set of assays on the Panther Fusion® system. You can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses from a single patient sample. Each Panther Fusion Respiratory assay can be processed independently or simultaneously with other Panther Fusion® and Aptima® assays.

          The Panther Fusion® SARS-CoV-2/Flu A/B/RSV, Panther Fusion® Flu A/B/RSV, Panther Fusion® Paraflu, Panther Fusion® AdV/hMPV/RV and Panther Fusion® Bordetella assays comprise the CE-IVD respiratory testing menu on the fully automated Panther Fusion system. Each is a multiplex, real-time PCR in vitro diagnostic test. These assays can be run on nasopharyngeal (NP) swab specimens obtained from individuals exhibiting signs and symptoms of a respiratory tract infection.1-5 Additionally, the Panther Fusion® SARS-CoV-2 assay has received Emergency Use Authorization for the detection of SARS-CoV-2 from nasopharyngeal, nasal, mid-turbinate and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal wash, and lower respiratory tract specimens.6

          Personalized Respiratory Testing

          The Panther Fusion assays provide the flexibility to run patient-specific targets, allowing for personalized patient testing and better cost control in your lab.

          •  
          • The Panther Fusion® SARS-CoV-2/Flu A/B/RSV assay§ - Qualitative detection and differentiation of SARS-CoV-2, influenza A virus, influenza B virus and respiratory syncytial virus.1
          • The Panther Fusion® Flu A/B/RSV assay - Qualitative detection and differentiation of influenza A virus, influenza B virus and respiratory syncytial virus.2
          • The Panther Fusion® AdV/hMPV/RV assay - Qualitative detection and differentiation of adenovirus, human metapneumovirus and rhinovirus.3
          •  
          •  
          • The Panther Fusion® Paraflu assay - Qualitative detection and differentiation of parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus and parainfluenza 4 virus.4
          • The Panther Fusion® Bordetella assay - Qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis.5
          • The Hologic® SARS-CoV-2 assays* - Qualitative detection of SARS-CoV-2 virus.6-8
          •  

          Flex Your Ability

          With the Panther Fusion Respiratory assays, a single patient specimen can be tested for SARS-CoV-2 as well as other common respiratory viruses which present with overlapping symptoms, boosting efficiency and increasing clinical insight.

          Additionally, when you leverage the power of Panther Fusion, your lab can:

          • Run more efficiently with full automation from sample-to-result.
             
          • Receive easy-to-interpret results.
             
          • Personalize syndromic respiratory testing by processing multiple assays from a single specimen.
             
          • Control costs by running only the required assays and reduce expense of unnecessary tests.
             
          • Eliminate the need for reagent preparation with Panther Fusion’s ready-to-use format.
             
          • Reduce waste with 60 day on-board reagent stability.
             
          • Consolidate menu onto a single, fully automated platform with the ability to run both Aptima and Panther Fusion assays alongside each other at the same time.

          Safety Data Sheets

          Need Support?

          All Other Requests

           

          * The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2 and Aptima SARS-CoV-2/Flu assays have not been FDA cleared or approved: These tests have been authorized by FDA under an EUA for use by authorized laboratories; The Aptima and Panther Fusion SARS-CoV-2 assays have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The Aptima SARS-CoV-2/Flu assay has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, Flu A virus, Flu B virus, and not for any other viruses or pathogens. The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2, and Aptima SARS-CoV-2/Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
           
          †The Panther Fusion Bordetella Assay is TGA approved and CE marked, it is not Health Canada approved.
          ‡The Panther Fusion SARS-CoV-2 Assay is Health Canada and TGA approved, it is not CE marked.
          §The Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay is CE marked, it is not Health Canada or TGA approved. In development and not for sale in the U.S.
          References: 1. Panther Fusion SARS-CoV-2/Flu A/B/RSV assay. Package insert AW-25328. Hologic, Inc.; 2022. 2. Panther Fusion A/B/RSV assay. Package insert AW-16162 Hologic, Inc.; 2018. 3. Panther Fusion AdV/hMPV/RV assay. Package insert AW-16164. Hologic, Inc.; 2019. 4. Panther Fusion Paraflu assay. Package insert AW-16163. Hologic, Inc.; 2018. 5. Panther Fusion Bordetella assay. Package insert AW-18637. Hologic, Inc.; 2018. 6. Panther Fusion SARS-CoV-2 assay. Package insert AW-21388. Hologic, Inc.; 2021. 7. Aptima SARS-CoV-2 assay. US package insert AW-21492-001. Hologic, Inc.; 2021. 8. Panther Fusion SARS-CoV-2/Flu assay. US package insert AW-22364. Hologic, Inc; 2021.